Philippine Oncology Center Corporation

What Philippine Oncology Center Corporation does

Philippine Oncology Center Corporation (POCC) is a privately held Philippine radiotherapy operator incorporated on October 22, 2008, that runs the country's first stand-alone integrated radiation therapy network. It delivers External Beam Radiotherapy (2D, 3D Conformal, IMRT, IGRT, and VMAT) and HDR Brachytherapy, supported by CT-Scan simulation, across five hospital-embedded centers in Quezon City, Manila, Cavite, La Union, and Baguio, with three additional locations planned. Its technology platform is built around Elekta linear accelerators and the Elekta Mosaiq Oncology Information System, which POCC positions as the only OIS deployment of its kind in the Philippines. The company is regulated by the Department of Health and the Philippine Nuclear Research Institute, and is accredited by PhilHealth, multiple HMOs, PCSO, and DSWD.

POCC's business model is a hospital-embedded managed-services model: it enters MOA and assumption-of-operations agreements with host medical institutions, supplies and maintains the linacs, CT simulators, and HDR brachytherapy units, staffs each site with board-certified radiation oncologists and a multi-disciplinary clinical team, and bills for radiotherapy procedures via PhilHealth reimbursement, HMO accreditation, and direct patient payment. Patient acquisition is driven primarily by physician referrals and oncology department networks at partner hospitals (JRRMMC, ManilaMed, DLSU Medical Center, Bethany Hospital, Saint Louis University, and St. Frances Cabrini Medical Center), with charity-funded channels through PCSO and DSWD extending access to lower-income patients under its "Walang-Mahirap CancerCare" positioning.

The organization is small, with approximately 33 employees spread across clinical operations and central functions, and is led by multiple Clinical Directors rather than a disclosed C-suite. Ownership structure, investors, and revenue figures are not publicly disclosed; no funding rounds, M&A, or external capital events appear in the available material. Strategic activity has been entirely organic and partnership-driven, with new sites added at roughly two-to-four-year intervals since 2011.

Name

Philippine Oncology Center Corporation

Legal name

Philippine Oncology Center Corporation

Website

https://philippineoncologycenter.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Philippine Oncology Center Corporation (POCC) operates the first stand-alone integrated radiation therapy network in the Philippines, delivering External Beam Radiotherapy, HDR Brachytherapy, and CT-Scan simulation through five hospital-embedded centers serving cancer patients across Luzon.

Ownership category

akta.pro rank

Product category

Radiation Oncology / Cancer Treatment Services

NAICS

Offices of Physicians (62111), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)

Keywords

• Radiation oncology
• Cancer treatment
• External beam radiotherapy
• Brachytherapy services
• Radiotherapy centers

Headquarters

HQ city

Quezon City

HQ country

Philippines

HQ region

Asia

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Radiotherapy Treatment Services: Revenue generated from external beam radiotherapy and HDR brachytherapy treatment procedures performed at POCC-operated centers embedded within partner hospitals.
2. HMO and PhilHealth Reimbursement: Accredited with Philippine Health Insurance Corporation (PhilHealth) and various Health Maintenance Organizations (HMOs), providing reimbursement for covered treatment services.
3. Hospital Partnership Administration: POCC assumes administration, management, and operation of radiotherapy departments within partner hospitals, generating revenue through service agreements and facility management contracts.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Philippine Oncology Center Corporation (POCC) operates a network of hospital-embedded radiotherapy centers across Luzon in the Philippines. It delivers External Beam Radiotherapy (2D, 3D Conformal, IMRT, IGRT, VMAT), High-Dose-Rate (HDR) Brachytherapy, and CT-Scan Simulation to cancer patients using Elekta linear accelerators and the Elekta Mosaiq oncology information system. The company also provides radiation oncologist consultation services across its five operational centers.

Product overview

The Philippine Oncology Center Corporation (POCC) operates as the first and only stand-alone integrated radiation therapy center in the Philippines, offering a network of five treatment centers across Luzon. The core portfolio consists of External Beam Radiotherapy services (encompassing 2D, 3D Conformal, IMRT, IGRT, and VMAT modalities) and HDR Brachytherapy, supported by CT-Scan Simulation for treatment planning. These services are delivered at five geographically distributed centers: FCC - Fairview Cancer Center (Quezon City), MCM - Radiation Therapy Unit (Manila), DLSU - Radiation Therapy Center (Cavite), BCC - Bethany Cancer Center (La Union), and SLU - SHMC Cancer Center (Baguio). POCC uses the Elekta Mosaiq oncology information system and is regulated by the Philippine Department of Health and Philippine Nuclear Research Institute.

Differentiator

Problem solved

Functional benefit

Products and services

• External Beam Radiotherapy

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• De La Salle University Medical Center (DLSUMC)coreStrategic or Co-development Partner · 1 August 2018Partnership forged for construction, supply, and operation of a radiotherapy center inside DLSUMC hospital compound. Cancer Center started clinical operations in August 2018. Located at Jose Sotto Tantiansu (JST) Cancer Center.
• Medical Center Manila (ManilaMed)coreStrategic or Co-development Partner · 8 December 2015MOA signed December 8, 2015. POCC established radiation therapy unit at ManilaMed's YWCA Annex Bldg., G/F, UN Avenue Ermita, Manila.
• St. Frances Cabrini Medical Center – Cancer InstituteminorStrategic or Co-development Partner · 1 September 2014On September 1, 2014, POCC assumed administration, management, and operation of the Department of Radiotherapy of St. Frances Cabrini Medical Center in Sto. Tomas, Batangas. Equipment includes 2 linear accelerators (1 with VMAT), 1 HDR brachytherapy afterloader, and 1 CT Scan.
• Jose R. Reyes Memorial Medical Center (JRRMMC)coreStrategic or Co-development Partner · 1 January 2011MOA signed with JRRMMC in Sta. Cruz, Manila. POCC assumed supply, operation, and maintenance of dedicated CT Scan for simulation, medical linear accelerator, and HDR brachytherapy. Clinical operations of JRRMMC-POCC Cancer Institute began January 1, 2011.
• Bethany Hospital Inc.coreStrategic or Co-development PartnerPOCC established a cancer care clinic at the basement of Bethany Hospital Inc., San Fernando City, La Union. Operates as Bethany Cancer Center (BCC).
• Saint Louis University (SLU)coreStrategic or Co-development PartnerPartnership with Saint Louis University in Baguio City. POCC operates the SLU Cancer Center / SHMC Cancer Center at Assumption Road, Baguio.

Scale indicators5 records

Recent moves13 records

Expansion highlights5 records

Direct peers

• Healthcare Global Enterprises (HCG): India's largest cancer care hospital network operating a multi-center oncology model with radiotherapy services across cities. Closest comparable to POCC's standalone, multi-center radiation oncology network in an emerging Asian market.
• ICON Group: Australian-headquartered oncology network with significant Asia-Pacific footprint offering radiation therapy and chemotherapy across multiple centers. Directly comparable multi-site cancer treatment operator with advanced radiotherapy technology.
• Cancer Treatment Centers of America (City of Hope): Specialty oncology network focused on advanced radiotherapy including IMRT, IGRT, and brachytherapy across multiple centers. A strong analog for POCC's single-modality specialty positioning and inter-disciplinary care model.
• GenesisCare: Global private cancer care provider with dense networks of standalone and hospital-embedded radiation oncology centers, including across Asia-Pacific. Closely mirrors POCC's specialty focus on radiotherapy and embedded-center operating model.

Broad incumbents

• Max Healthcare: Major North India hospital network with established radiation oncology programs across multiple tertiary hospitals. Comparable in offering hospital-embedded advanced radiotherapy but with broader service portfolio.
• Apollo Hospitals: Large pan-India hospital chain with significant oncology departments offering radiation therapy including IMRT/IGRT. Overlaps with POCC in radiation oncology services but operates across broader clinical specialties.
• Tata Memorial Hospital: India's premier specialty cancer hospital providing comprehensive radiation oncology including brachytherapy and advanced linear-accelerator services. Comparable as a leading regional radiation oncology reference center in an emerging Asian market.

Others

• Elekta: Swedish manufacturer of linear accelerators, brachytherapy afterloaders, and the Mosaiq Oncology Information System that POCC operates. Adjacent ecosystem participant providing the proprietary technology stack underpinning POCC's services.
• Varian (Siemens Healthineers): Global radiotherapy equipment manufacturer and oncology software provider, now part of Siemens Healthineers. Key technology supplier in the radiation oncology ecosystem and adjacent to POCC's service delivery model.

Regional players

• Bumrungrad International Hospital: Leading Southeast Asian private tertiary hospital in Thailand offering radiotherapy and oncology services to regional and medical-tourism patients. Comparable as a regional private provider of advanced cancer care but in a different geography than POCC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/philippine-oncology-center-corporation

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Philippine Oncology Center Corporation